The aim of this study was to determine whether tumor RNA-transfected CD40-activated B cells could safely induce anti-tumor immunity and impact the natural history of spontaneous NHL in dogs after remission induction with chemotherapy. The gene discussed is CD40; the disease is non-Hodgkin lymphoma.